Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Ocular Therapeutix, Inc. clinical trials
The registry lists 33 studies whose lead sponsor is Ocular Therapeutix, Inc.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 3, 2026.
Keep track of what changes. Save the Ocular Therapeutix, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ocular Therapeutix, Inc..
- Ocular Therapeutix, Inc.33 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 33 of 33.
- Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 StudyRecruitingNCT07516132Phase 3
- A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic RetinopathyRecruitingNCT07235085Phase 3
- A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT05335122Phase 2
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular DegenerationActive, not recruitingNCT06495918Phase 3
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationActive, not recruitingNCT06223958Phase 3
- CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular HypertensionCompletedNCT04360174Phase 1
- OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)CompletedNCT05814757Phase 2
- CLN-0046: Treatment of AMD Subjects With OTX-TKICompletedNCT03630315Phase 1
- A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric CataractCompletedNCT04539548Phase 3
- Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular DegenerationCompletedNCT04989699Phase 1
- Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic RetinopathyActive, not recruitingNCT05695417Phase 1
- Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.CompletedNCT04362670Phase 1/2
- A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular InsertCompletedNCT04061044Phase 3
- To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye DiseaseCompletedNCT04747977Phase 2
- A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy SubjectsTerminatedNCT04945824Early Phase 1
- An Observational, Qualitative Study Assessing Eye Drop AdministrationStatus unknownNCT05307081
- Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract SurgeryCompletedNCT01666210Phase 2
- Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHTCompletedNCT02914509Phase 3
- A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic ConjunctivitisCompletedNCT04050865Phase 3
- I-ZIP Ocular Bandage Pivotal StudyCompletedNCT00774228Not applicable
- OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02988882Phase 3
- OTX-14-002: Device Exposure RegistryWithdrawnNCT02309736
- Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract SurgeryCompletedNCT02034019Phase 3
- OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract SurgeryCompletedNCT02089113Phase 3
- OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02062905Phase 2
- OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisCompletedNCT02445326Phase 3
- OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry EyeCompletedNCT02468700Phase 2
- OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract SurgeryCompletedNCT02736175Phase 3
- Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular HypertensionCompletedNCT02312544Phase 2
- ReSure Sealant Pivotal StudyCompletedNCT01498224Phase 3
- Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle GlaucomaCompletedNCT01845038Phase 1
- ReSure Sealant Post Approval StudyCompletedNCT02310815
- Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum PlugStatus unknownNCT01800175Phase 1